Can Bioplus bounce back from revenue stagnation after PE investor's exit?
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Can Bioplus bounce back from revenue stagnation after PE investor's exit?

Can Bioplus bounce back from revenue stagnation after PE investor's exit?

By Sreeja Biswas

  • 06 Jun 2024
Premium
Can Bioplus bounce back from revenue stagnation after PE investor's exit?
Sundeep Aurora, chairman and CEO, Bioplus Lifesciences | Credit: Linkedin

Healthcare supplements maker Bioplus Life Sciences Pvt. Ltd, which was a portfolio company for Asia-focused private ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.
Advertisement

Related Articles

Pro
Creador stares at a tepid exit from nine-year-old healthcare portfolio firm

Healthcare

Creador stares at a tepid exit from nine-year-old healthcare portfolio firm

Kedaara-backed Neurealm acquires healthcare tech services firm Veersa

Healthcare

Kedaara-backed Neurealm acquires healthcare tech services firm Veersa

Pro
Kedaara's public markets fund adds Jhunjhunwala family-backed firm to portfolio

Healthcare

Kedaara's public markets fund adds Jhunjhunwala family-backed firm to portfolio

Premium
Nabventures-backed Avis Hospitals in talks to snag PE funding

Healthcare

Nabventures-backed Avis Hospitals in talks to snag PE funding

Premium
PE-backed drugmaker Brinton eyes fresh fundraise, hires banker

Healthcare

PE-backed drugmaker Brinton eyes fresh fundraise, hires banker

Premium
Tata 1mg hits the pedal on cluster-driven expansion

Healthcare

Tata 1mg hits the pedal on cluster-driven expansion

Premium
Health-tech startup Aurae eyes pre-Series A funding round

Healthcare

Health-tech startup Aurae eyes pre-Series A funding round

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW